Get started
Author

Alessandro Limongelli

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024 · Jon Salmanton-García, Francesco Marchesi, et al. · EClinicalMedicine · 35
PDF
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring
2024 · Malgorzata Mikulska, Monica Melchio, et al. · Journal of Antimicrobial Chemotherapy · 26
PDF
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study
2025 · Antonio Vena, Giusy Tiseo, et al. · Clinical Infectious Diseases · 25
Persistent candidemia caused by different Candida species: Data from a multicenter contemporary cohort
2025 · Giusy Tiseo, Antonio Vena, et al. · Journal of Infection · 22
PDF
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?
2022 · Antonio Vena, Nadia Castaldo, et al. · Expert Opinion on Pharmacotherapy · 22
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies
2024 · Margherita Bellucci, Federica Maria Bozzano, et al. · Frontiers in Immunology · 20
PDF
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
2023 · Giuseppe Rossi, Jon Salmanton-García, et al. · International Journal of Infectious Diseases · 19
PDF
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA ‐ EPIFLUEHA Report
2024 · Jon Salmanton‐García, Francesco Marchesi, et al. · American Journal of Hematology · 17
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
2023 · Jon Salmanton-García, Francesco Marchesi, et al. · International Journal of Antimicrobial Agents · 17
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
2023 · Pellegrino Musto, Jon Salmanton‐García, et al. · Hematological Oncology · 16
PDF
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression
2022 · Antonio Vena, Luca Traman, et al. · Vaccines · 16
PDF
Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND project
2023 · Daniele Roberto Giacobbe, Cristina Marelli, et al. · Annals of Medicine · 15
PDF
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience
2025 · Francesca Serapide, Riccardo Serraino, et al. · Journal of Antimicrobial Chemotherapy · 10
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
2024 · Tobias Lahmer, Jon Salmanton-García, et al. · Infection · 10
Rezafungin Utilisation in Real Life— FungiScope Results From Europe and the United States
2025 · Ilana Reinhold, Giovanni Mori, et al. · Mycoses · 9
PDF
Deep Learning for the Early Diagnosis of Candidemia
2025 · Daniele Roberto Giacobbe, Sabrina Guastavino, et al. · Infectious Diseases and Therapy · 7
PDF
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry
2024 · Tommaso Francesco Aiello, Jon Salmanton-Garcia, et al. · Haematologica · 7
PDF
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia
2023 · Daniele Roberto Giacobbe, Sara Mora, et al. · Diagnostics · 6
PDF
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients
2024 · Nadia Castaldo, Antonio Vena, et al. · Current Opinion in Infectious Diseases · 4
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study
2025 · Daniele Roberto Giacobbe, Greta Cattardico, et al. · Critical Care · 3
PDF
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry
2025 · Jon Salmanton‐García, Francesco Marchesi, et al. · American Journal of Hematology · 2
PDF
Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant Candida parapsilosis bloodstream infections
2025 · Antonio Vena, Claudia Bartalucci, et al. · Antimicrobial Agents and Chemotherapy · 2
Dexamethasone Treatment for COVID-19 is Related with Increased Mortality in Haematological Malignancy Patients: Results from the EPICOVIDEHA Registry
2023 · Tommaso Francesco Aiello, Jon Salmanton-Garcia, et al. · SSRN Electronic Journal · 2
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry
2026 · Jon Salmanton-García, Francesco Marchesi, et al. · Open Forum Infectious Diseases · 1
Letter: Case Report: 12 Months Persisting Subcutaneous Nodule After Long-Acting Cabotegravir/Rilpivirine Administration
2025 · Alessandro Limongelli, Giovanni Massobrio, et al. · AIDS Patient Care and STDs · 1
Works count: 41
Citation count: 315
H-index: 12
I10-index: 14
Year
Topic
Type